Sanofi's recently-appointed Consumer Healthcare head Julie Van Ongevalle says she has identified "untapped potential" for the business to utilize "cutting edge digital platforms." Van Ongevalle revealed her early plans for Sanofi as it reported a drop in Q3 sales.

GSK's Brian McNamara says the firm has hit its £1bn brand divestment target which will help fund the restructuring of its Consumer Healthcare business before it is spun off in 2022.

Two leading, independent bodies of French scientists, doctors and pharmacists are calling for OTC drugs containing pseudoephedrine to be reverse-switched to prescription-only status over safety fears.